Dr. Annika Lückemann, LL.M.

As a Partner in our Intellectual Property Group, I represent national and international companies in all matters of intellectual property. My particular focus lies on litigating patents from all technical areas, including the co-ordination of international patent disputes.

Over the years I have developed extensive experience in patent litigation before the German civil courts, the co-ordination of international patent disputes, as well as collaboration with patent attorneys in parallel revocation actions (Federal Patent Court, Federal Supreme Court and EPO). I have sound expertise with cases from the healthcare and life sciences sector, as well as in the areas of chemistry, telecommunications and mechanics. I specifically offer advice in preliminary injunction proceedings (including cross-border scenarios, seizures and preparation of protective letters). I also regularly work on contractual IP matters and have a thorough understanding of Supplementary Protection Certificates.

• Defending companies from all industry sectors against patent infringement allegations (preliminary injunction proceedings; main actions and seizures).
• Analysis of intellectual property rights and their strategic enforcement.
• Co-ordination of international patent litigation and close cooperation with foreign counsel.
• Litigation and advice on second medical use patents, on Supplementary Protection Certificates (SPC) and on standard-essential patents (SEP).
• Contribution in various revocation proceedings before the German Federal Patent Court, the German Federal Supreme Court and the EPO.

• Successful defence of a generic manufacturer in preliminary injunction proceedings on the basis of a Supplementary Protection Certificate (Ezetimibe/Simvastatin).
• Successful defence of generic manufacturers in second medical use patent cases (Fulvestrant, Pregabalin).
• Extensive international patent litigation for Fisher & Paykel Healthcare, including preliminary injunctions and main actions (defensive and offensive) regarding medical devices.
• Patent infringement action in the telecommunications sector (Nokia v. Apple).
• Advice in patent litigation regarding chip technology (Polaris v. Nvidia).